YanAn Bicon Pharmaceutical Listed Co (SZSE:002411) EV-to-EBIT : -1.09 (As of Jun. 24, 2024)

YanAn Bicon Pharmaceutical Listed Co EV-to-EBIT Chart

YanAn Bicon Pharmaceutical Listed Co Annual Data
	Trend	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22
EV-to-EBIT		Get a 7-Day Free Trial					43.12	31.71	739.88	-2,345.86	-8.65

YanAn Bicon Pharmaceutical Listed Co Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
EV-to-EBIT	Get a 7-Day Free Trial															66.93	116.68	-61.69	-8.65	-4.88

Competitive Comparison of YanAn Bicon Pharmaceutical Listed Co's EV-to-EBIT

For the Chemicals subindustry, YanAn Bicon Pharmaceutical Listed Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YanAn Bicon Pharmaceutical Listed Co's EV-to-EBIT Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, YanAn Bicon Pharmaceutical Listed Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where YanAn Bicon Pharmaceutical Listed Co's EV-to-EBIT falls into.

YanAn Bicon Pharmaceutical Listed Co EV-to-EBIT Calculation

YanAn Bicon Pharmaceutical Listed Co's EV-to-EBIT for today is calculated as:

YanAn Bicon Pharmaceutical Listed Co's current Enterprise Value is ¥2,170 Mil.
YanAn Bicon Pharmaceutical Listed Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1,989 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

YanAn Bicon Pharmaceutical Listed Co  (SZSE:002411) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

YanAn Bicon Pharmaceutical Listed Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2023 is calculated as:

YanAn Bicon Pharmaceutical Listed Co's Enterprise Value for the quarter that ended in Mar. 2023 was ¥9,713 Mil.
YanAn Bicon Pharmaceutical Listed Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1,989 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

YanAn Bicon Pharmaceutical Listed Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of YanAn Bicon Pharmaceutical Listed Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

YanAn Bicon Pharmaceutical Listed Co (SZSE:002411) Business Description